RMR Wealth Builders’s BioMarin Pharmaceuticals BMRN Stock Holding History

RMR Wealth Builders’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$146K	Buy	+1,726	New	+$130K	0.14%	136

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

RMR Wealth Builders's BMRN Position: Q4 2019 in Review

RMR Wealth Builders opened a new position in BioMarin Pharmaceuticals (BMRN) in Q4 2019: 1,726 shares worth $146K. The stake represents 0.14% of the portfolio and ranks #136 among its holdings.

468 funds tracked by Wall St. Rank hold BMRN as of Q4 2019.

RMR Wealth Builders held 1,726 shares of BioMarin Pharmaceuticals worth $146K as of Q4 2019.
BioMarin Pharmaceuticals was a new RMR Wealth Builders position in Q4 2019.
BioMarin Pharmaceuticals made up 0.14% of RMR Wealth Builders's portfolio in Q4 2019, its #136 holding.
468 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2019.

Based on RMR Wealth Builders's 13F filing for Q4 2019, filed 3 Mar 2020.